Vsee Health (VSEE) Cash & Equivalents (2021 - 2026)

Vsee Health (VSEE) has reported Cash & Equivalents for 6 consecutive years, with $454151.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cash & Equivalents rose 55.75% year-over-year to $454151.0; the trailing twelve-month figure through Jun 2026 stood at $454151.0 (up 55.75% YoY), and the FY2025 full-year result was $5.1 million, up 1448.98% from the prior year.
• Cash & Equivalents slipped to $454151.0 in Q2 2026 per VSEE's latest filing, from $1.3 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $5.1 million in Q4 2025 and bottomed at $507.0 in Q3 2023.
• Historically, Cash & Equivalents has averaged $731181.5 across 5 years, with a median of $308855.0 in 2024.
• The sharpest annual moves came in 2023 and 2024: Cash & Equivalents sank 98.87% in 2023, then surged 458940.83% in 2024.
• Over 5 years, Cash & Equivalents stood at $106998.0 in 2022, then advanced by 10.97% to $118734.0 in 2023, then surged by 174.66% to $326115.0 in 2024, then soared by 1448.98% to $5.1 million in 2025, then plunged by 91.01% to $454151.0 in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $454151.0, $1.3 million, and $5.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.